SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-021059
Filing Date
2020-08-10
Accepted
2020-08-10 09:00:18
Documents
3
Period of Report
2020-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea125254-8k_hoththerap.htm 8-K 20155
2 PRESS RELEASE DATED AUGUST 10, 2020 ea125254ex99-1_hoth.htm EX-99.1 14794
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3867
  Complete submission text file 0001213900-20-021059.txt   41555
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 201087352
SIC: 2834 Pharmaceutical Preparations